Publications

Found 1 results
Filters: Author is B.-G. Liu  [Clear All Filters]
2012
H. Wu, Liu, B. - G., Liu, J. - H., Pan, Y. - S., Yuan, L., and Hu, G. - Z., Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province, China, vol. 11, pp. 3357-3364, 2012.
Bauernfeind A, Chong Y and Schweighart S (1989). Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17: 316-321. http://dx.doi.org/10.1007/BF01650718 PMid:2689349 Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-51. http://dx.doi.org/10.1128/CMR.14.4.933-951.2001 PMid:11585791 PMCid:89009 Bradford PA, Urban C, Mariano N, Projan SJ, et al. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 41: 563-569. PMid:9055993 PMCid:163751 Chen Y, Cheng J, Wang Q, Ye Y, et al. (2009). ACT-3, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. Int. J. Antimicrob. Agents 33: 95-96. http://dx.doi.org/10.1016/j.ijantimicag.2008.06.026 PMid:18789849 Clinical and Laboratory Standards Institute (2008a). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement (M100-S16) CLSI. Wayne. Clinical and Laboratory Standards Institute (2008b). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals Approved Standard. 3rd edn. (M31-A3) CLSI, Wayne. PMid:21581504 PMCid:2967878 Coudron PE, Moland ES and Thomson KS (2000). Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38: 1791-1796. PMid:10790101 PMCid:86590 Coudron PE, Hanson ND and Climo MW (2003). Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J. Clin. Microbiol. 41: 772-777. http://dx.doi.org/10.1128/JCM.41.2.772-777.2003 PMid:12574281 PMCid:149714 De Champs C, Sirot D, Chanal C, Bonnet R, et al. (2000). A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrob. Agents Chemother. 44: 3177-3179. http://dx.doi.org/10.1128/AAC.44.11.3177-3179.2000 PMid:11036046 PMCid:101626 Doi Y and Paterson DL (2007). Detection of plasmid-mediated class C β-lactamases. Int. J. Infect. Dis. 11: 191-197. http://dx.doi.org/10.1016/j.ijid.2006.07.008 PMid:17339123 Feizabadi MM, Delfani S, Raji N, Majnooni A, et al. (2010). Distribution of blaTEM, blaSHV, blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb. Drug Resist. 16: 49-53. http://dx.doi.org/10.1089/mdr.2009.0096 PMid:19961397 Hu GZ, Chen HY, Si HB, Deng LX, et al. (2008). Phenotypic and molecular characterization of TEM-116 extended-spectrum β-lactamase produced by a Shigella flexneri clinical isolate from chickens. FEMS Microbiol. Lett. 279: 162-166. http://dx.doi.org/10.1111/j.1574-6968.2007.01017.x PMid:18093137 Khalaf NG, Eletreby MM and Hanson ND (2009). Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect. Dis. 9: 84. http://dx.doi.org/10.1186/1471-2334-9-84 PMid:19497111 PMCid:2701952 Ko KS, Yeom JS, Lee MY, Peck KR, et al. (2008). Clonal dissemination of extended-spectrum β-lactamase (ESBL)- producing Klebsiella pneumoniae isolates in a Korean hospital. J. Korean Med. Sci. 23: 53-60. http://dx.doi.org/10.3346/jkms.2008.23.1.53 PMid:18303199 PMCid:2526503 Lartigue MF, Zinsus C, Wenger A, Bille J, et al. (2007) Extended Spectrum β-Lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51: 2855-2860. http://dx.doi.org/10.1128/AAC.01614-06 PMid:17470647 PMCid:1932552 Lautenbach E, Strom BL, Bilker WB, Patel JB, et al. (2001). Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33: 1288-1294. http://dx.doi.org/10.1086/322667 PMid:11565067 Lavigne JP, Bonnet R, Michaux-Charachon S, Jourdan J, et al. (2004). Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum β-lactamase-producing Gram-negative bacteria. J. Antimicrob. Chemother. 53: 616-619. http://dx.doi.org/10.1093/jac/dkh140 PMid:14985275 Papanicolaou GA, Medeiros AA and Jacoby GA (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34: 2200-2209. http://dx.doi.org/10.1128/AAC.34.11.2200 PMid:1963529 PMCid:172023 Paterson DL and Bonomo RA (2005). Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18: 657-686. http://dx.doi.org/10.1128/CMR.18.4.657-686.2005 PMid:16223952 PMCid:1265908 Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, et al. (2000). Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30: 473-478. http://dx.doi.org/10.1086/313719 PMid:10722430 Queenan AM, Foleno B, Gownley C, Wira E, et al. (2004). Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J. Clin. Microbiol. 42: 269-275. http://dx.doi.org/10.1128/JCM.42.1.269-275.2004 PMid:14715764 PMCid:321709 Sirot D (1995). Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36 Suppl A: 19-34. Tenover FC, Emery SL, Spiegel CA, Bradford PA, et al. (2009). Identification of plasmid-mediated AmpC β-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J. Clin. Microbiol. 47: 294-299. http://dx.doi.org/10.1128/JCM.01797-08 PMid:19036936 PMCid:2643671 Winokur PL, Canton R, Casellas JM and Legakis N (2001). Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32 Suppl 2: S94-103. http://dx.doi.org/10.1086/320182 PMid:11320450 Yuan L, Liu JH, Hu GZ, Pan YS, et al. (2009). Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli isolates from chickens in Henan Province, China. J. Med. Microbiol. 58: 1449-1453. http://dx.doi.org/10.1099/jmm.0.012229-0 PMid:19574412